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Going Backward to Go Forward*Robert J. Applegate, MDC hronic total conclusions (CTOs) have longbeen considered among the most chal-lenging lesion subsets for percutaneous
coronary intervention (PCI). The basis for this belief
is multifactorial, including the absence or subtlety
of perceived patient symptoms, assumptions that
CTOs are often associated with minimally viable or
infarcted tissue, technical difﬁculties leading to less
procedural success than for non-CTO lesions, and a
lack of strong randomized clinical trial data demon-
strating a beneﬁt of PCI on clinical outcomes. Despite
this prevailing notion of the limited role of PCI for
CTO in contemporary practice, the relative reluctance
to attempt PCI for CTOs is waning as better under-
standing of CTOs’ importance to the clinical out-
comes of patients, improvements in device and
stent design leading to more procedural success and
better outcomes, and greater experience of dedicated
operators have cast PCI for CTOs in a new light.
When a CTO is approached with a procedural
strategy similar to that used for non-CTOs, the pro-
cedural success rate is much lower than for non-CTO
PCI, often resulting in lengthy procedures and frus-
trated operators. The recognition that traditional
single-wire techniques were not adequate to achieve
high procedural success rates led to the development
of newer techniques, including antegrade techniques
such as multiple parallel wires, subintimal tracking
with reentry (controlled antegrade retrograde
tracking), and retrograde approaches taking advan-
tage of septal and epicardial collateral channels.*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
From Wake Forest School of Medicine, Winston Salem, North Carolina.
Dr. Applegate is a member of the advisory board of Abbott Vascular.Although the antegrade approach has been the
preferred approach for most cases and operators, the
belief that skill with a retrograde approach to CTOs
may result in the highest overall rates of procedural
success has been gaining popularity.
The retrograde approach was introduced and
developed by a group of Japanese operators who
demonstrated not only the feasibility of this approach
but a high procedural success rate accompanied by a
low rate of procedural complications (84.8% and 1.6%
overall, respectively, in the most recent registry) (1).
Whether this approach and technique could be
exported to other countries and operators has been
the subject of ongoing study. The ERCTO (European
Registry of Chronic Total Occlusion) was formed in
January 2008 as a prospective registry to monitor the
adoption and utilization of the PCI approach to CTOs
at 16 centers throughout Europe. This group recog-
nized the commitment required to adopt this tech-
nique as well as the need to provide a more objective
basis of reporting procedural and long-term outcomes
(to 3 years). The publication of their initial procedural
and in-hospital experience in 2011 in 1,914 patients
detailed an 82.9% overall procedural success rate and
a reasonable rate of complications (2). A retrograde
approach was used in 11.8% of all CTO cases. There
was a lower success rate (64.5%; p < 0.05 vs. ante-
grade), more contrast use, and longer ﬂuoroscopy
times with a retrograde approach than with the
antegrade approach, as well as a higher incidence of
coronary artery perforation (although no difference in
30-day major adverse cardiovascular event rates was
noted between the 2 approaches). At the same time
the ERCTO results were published, the initial retro-
grade experience of 3 U.S. “dedicated” centers was
reported (3). The procedural success rates (79.4%) as
well as the rate of complications (2.6%) were strik-
ingly similar to those of the Japanese experience,
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of cases involved patients with prior coronary artery
bypass grafting and PCI of CTOs performed for failed
saphenous vein grafts.SEE PAGE 2388In this issue of the Journal, the ERCTO group re-
ports a follow-up of their initial PCI for CTO outcomes,
detailing their retrograde CTO experience (4). The
retrograde approach was used to treat 1,582 lesions in
1,395 patients. Over the 5-year study period, use of the
retrograde approach increased from 11.8% in 2008 of
all PCIs for CTOs to 25% in 2012. The overall success
rate was 75.3%, substantially higher when the retro-
grade approach was chosen initially (82.2% success)
rather than as a bailout for a failed antegrade approach
(53.1% success). Procedural complications occurred in
6.8% of cases, driven principally by collateral channel
perforation or hematoma and donor vessel thrombus
or dissection, but the retrograde approach was asso-
ciated with a very low overall in-hospital rate of major
adverse cardiovascular and cerebrovascular events of
0.8%. Clinical follow-up was available in 66.7% of all
patients, with a mean of 24.7  15.0 months of follow-
up. The overall rate of major adverse cardiovascular
and cerebrovascular events was 13.6%, with a mor-
tality rate of 1.9%, worse in those with failed pro-
cedures (4.3% vs. 0.6%; p < 0.001). Although the
durability of CTO PCI has been questioned, the ERCTO
experience indicates that clinical beneﬁts of angina
and dyspnea reduction persisted out to 3 years of
follow-up, suggesting that the beneﬁts are durable.
What should the general interventional cardiology
community take away from these observations?
Important issues to address in answering this broad
question include whether these results are achievable
by general interventionalists, whether these im-
proved results will translate into meaningful clinical
outcomes, and ultimately whether higher procedural
success with lower complication rates will increase
the propensity to choose or attempt PCI for a CTO
(vs. coronary artery bypass grafting) within the gen-
eral interventional community. With regard to the
ﬁrst issue, the results of the ERCTO study were ach-
ieved by operators whose skills and experience were
acquired over a period of time, with commitment to a
dedicated CTO practice. These operators also openly
and frequently shared CTO successes and failures at
national and international meetings and gatherings,
quickly raising the level of knowledge surrounding
important technical aspects of PCI for CTOs. The in-
vestigators show that minimal procedure experience
was associated with lower procedural success, but the
point of true competence in the learning curve forCTOs remains uncertain. Whether concerted efforts
to provide specialized training for PCI for CTO will
allow generalization of this procedure into main-
stream interventional practices remains to be deter-
mined, but most signals indicate that there has been
movement in this direction. Nonetheless, at least at
this point in time, it appears that PCI for CTO will not
be a mature skill set for fellows coming out of tradi-
tional 1-year training programs, nor for general
interventional cardiologists, and will require addi-
tional post-graduate training to achieve.
Whether better PCI of CTO outcomes will result in
meaningful improvements in patient outcomes re-
mains to be determined. The reader is referred to a
recent review in the Journal by Strauss et al. (5), who
carefully and thoughtfully considered the concerns
surrounding PCI for CTO as well as the evidence base
supporting the potential beneﬁts of complete revas-
cularization (CR). In their aptly titled piece, “Revas-
cularization of Chronic Total Occlusions: Time to
Reconsider?” the investigators presented a cogent
argument for wider adoption of CR, which in PCI
terms means percutaneous treatment for CTOs. It
must be acknowledged that the deﬁnitive evidence
base for CR awaits the results of randomized clinical
trials such as DECISION-CTO (Drug-Eluting Stent Im-
plantation Versus Optimal Medical Treatment in Pa-
tients With Chronic Total Occlusion) and EURO-CTO
(European Study on the Utilization of Revasculariza-
tion Versus Optimal Medical Therapy for the Treat-
ment of Chronic Total Coronary Occlusions). At least
for now, better procedural success and outcomes
such as those reported in ERCTO provide a stronger
foundation to evaluate the impact of CR achieved by
PCI for CTO on overall patient outcomes.
Finally, whether the observations of ERCTO will
inﬂuence rank-and-ﬁle interventionalists’, or even
general cardiologists’, propensity to choose or attempt
PCI for a CTO as opposed to sending the patient for
coronary artery bypass grafting remains to be deter-
mined. The issues are complex, and it may come down
to a decision based on the potential impact of a CTO
program on overall catheterization laboratory utiliza-
tion. As noted above, procedure times are longer for
CTO than non-CTO procedures, and lengthy pro-
cedures interrupt ﬂow within the catheterization lab-
oratory. Also, almost all experts advocate that
2 operators jointly perform PCI for a CTO. These
2 factors require programmatic commitment and re-
sources for a CTO program, including dedicated cath-
eterization laboratory time that goes well beyond that
required of a non-CTO PCI program. Additionally,
although ERCTO and other dedicated CTO operators
have substantially reduced the complication rates
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retrograde experience was associated with a coronary
perforation rate of almost 5%, requiring urgent peri-
cardiocentesis in a large minority of patients. The
counterarguments raised by many CTO experts are
that improved techniques are being translated into
lower complication rates, that their overall PCI skills
are improved considerably, and that it is valuable to
the entire revascularization program to be able to offer
PCI for CTO to patients believed to have no options atnon-CTO centers (6). While we await the results of
randomized clinical trials, CTO experiences such as
published here by ERCTO indicate that going backward
may indeed mean going forward.
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